Comparison of Fluconazole (UK-49,858) and Amphotericin B for Maintenance Treatment of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome
Led by Pfizer · Updated on 2011-03-14
330
Participants Needed
28
Research Sites
N/A
Total Duration
On this page
AI-Summary
Official Title
Who Can Participate
Trial Site Locations
How is the study designed?
Frequently Asked Questions
Research Publications
Sponsors
P
Pfizer
Lead Sponsor
N
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborating Sponsor
AI-Summary
What this Trial Is About
To compare the safety and effectiveness of a new drug, fluconazole, with that of the usual therapy, amphotericin B, in the prevention of a relapse of cryptococcal meningitis (CM) in patients with AIDS who have been successfully treated for acute CM in the last 6 months.
Cryptococcal meningitis is a life-threatening infectious complication of AIDS. Because relapse after treatment occurs in over 50 percent of cases, chronic maintenance therapy with intravenous (IV) amphotericin B is usually given. However, amphotericin B is not always effective, has toxic effects, and must be given by the intravenous route. Fluconazole is an antifungal agent that can be given orally and has been shown to be effective against cryptococcal infections in animals and against acute CM in a few AIDS patients. Also, the side effects experienced by over 2000 patients or volunteers given fluconazole have seldom been severe enough to require withdrawal of the drug.
CONDITIONS
Official Title
Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Inclusion Criteria
HIV infection documented by antibody (ELISA on two occasions or ELISA with Western blot confirmation), p24 antigen testing, or recovery of HIV in culture.
Prior Medication:
Required:
Minimum total dose of 15 mg/kg of amphotericin B (either alone or in combination with flucytosine) during primary therapy. End of primary therapy within 6 weeks of start of maintenance therapy.
Allowed:
Past or present antiviral therapy and prophylaxis for Pneumocystis carinii pneumonia (PCP).
Pfizer must be notified if the patient is receiving ganciclovir at entry. Allowed with amphotericin B to treat or prevent side effects.
Antipyretics.
Hydrocortisone.
Meperidine.
Exclusion Criteria
Co-existing Condition:
Patients with the following are excluded:
Clinical evidence of acute or chronic meningitis other than cryptococcosis.
Allergy or intolerance of imidazoles, azoles, or amphotericin B. Unable to take oral medications reliably.
Patients with the following are excluded:
Clinical evidence of acute or chronic meningitis other than cryptococcosis.
Allergy or intolerance of imidazoles, azoles, or amphotericin B.
Prior Medication:
Excluded for more than 7 days after initiation of primary therapy for cryptococcosis:
Ketoconazole.
Fluconazole.
Itraconazole.
Miconazole.
Any other systemic imidazole or azole.
Excluded:
Intrathecal amphotericin B.
Coumadin-type anticoagulants.
Oral hypoglycemics.
Barbiturates.
Phenytoin.
Immunostimulants.
Investigational drug or approved (licensed) drugs for investigational indications.
Prior Treatment:
Excluded:
Lymphocyte replacement.
You will not qualify if you...
History of severe allergic reactions to study medication
Currently pregnant or breastfeeding
Recent participation in another clinical trial within the last 30 days
Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Total: 28 locations
1
UCLA CARE Ctr
Los Angeles, California, United States, 90095
Status Unknown
2
Univ of Miami School of Medicine
Miami, Florida, United States, 331361013
Status Unknown
3
Indiana Univ Hosp
Indianapolis, Indiana, United States, 462025250
Status Unknown
4
Louisiana State Univ School of Medicine
New Orleans, Louisiana, United States, 70112
Status Unknown
5
Tulane Univ School of Medicine
New Orleans, Louisiana, United States, 70112
Status Unknown
6
Johns Hopkins Hosp
Baltimore, Maryland, United States, 21287
Status Unknown
7
Harvard (Massachusetts Gen Hosp)
Boston, Massachusetts, United States, 02114
Status Unknown
8
Beth Israel Deaconess - West Campus
Boston, Massachusetts, United States, 02215
Status Unknown
9
SUNY / Erie County Med Ctr at Buffalo
Buffalo, New York, United States, 14215
Status Unknown
10
City Hosp Ctr at Elmhurst / Mount Sinai Hosp
Elmhurst, New York, United States, 11373
Status Unknown
11
Beth Israel Med Ctr / Peter Krueger Clinic
New York, New York, United States, 10003
Status Unknown
12
Bellevue Hosp / New York Univ Med Ctr
New York, New York, United States, 10016
Status Unknown
13
Cornell Univ Med Ctr
New York, New York, United States, 10021
Status Unknown
14
Mem Sloan - Kettering Cancer Ctr
New York, New York, United States, 10021
Status Unknown
15
Saint Luke's - Roosevelt Hosp Ctr
New York, New York, United States, 10025
Status Unknown
16
Mount Sinai Med Ctr
New York, New York, United States, 10029
Status Unknown
17
Univ of Rochester Medical Center
Rochester, New York, United States, 14642
Status Unknown
18
SUNY - Stony Brook
Stony Brook, New York, United States, 117948153
Status Unknown
19
Jack Weiler Hosp / Bronx Municipal Hosp
The Bronx, New York, United States, 10465
Status Unknown
20
Montefiore Med Ctr / Bronx Municipal Hosp
The Bronx, New York, United States, 10467
Status Unknown
21
North Central Bronx Hosp / Bronx Municipal Hosp
The Bronx, New York, United States, 10467
Status Unknown
22
Bronx Veterans Administration / Mount Sinai Hosp
The Bronx, New York, United States, 10468
Status Unknown
23
Univ of North Carolina
Chapel Hill, North Carolina, United States, 275997215
Status Unknown
24
Duke Univ Med Ctr
Durham, North Carolina, United States, 27710
Status Unknown
25
Holmes Hosp / Univ of Cincinnati Med Ctr
Cincinnati, Ohio, United States, 452670405
Status Unknown
26
Univ Hosp of Cleveland / Case Western Reserve Univ
Cleveland, Ohio, United States, 44106
Status Unknown
27
Ohio State Univ Hosp Clinic
Columbus, Ohio, United States, 432101228
Status Unknown
28
Julio Arroyo
West Columbia, South Carolina, United States, 29169
Status Unknown
Loading map...
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
N/A
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.